EA200100967A1 - Новое иммунодепрессивное средство - Google Patents

Новое иммунодепрессивное средство

Info

Publication number
EA200100967A1
EA200100967A1 EA200100967A EA200100967A EA200100967A1 EA 200100967 A1 EA200100967 A1 EA 200100967A1 EA 200100967 A EA200100967 A EA 200100967A EA 200100967 A EA200100967 A EA 200100967A EA 200100967 A1 EA200100967 A1 EA 200100967A1
Authority
EA
Eurasian Patent Office
Prior art keywords
depressive
new immune
chem
independently
formula
Prior art date
Application number
EA200100967A
Other languages
English (en)
Other versions
EA003098B1 (ru
Inventor
Такаюки Ямазаки
Фумио Сугавара
Кейсуке Охта
Казуйоси Масаки
Котаро Накаяма
Кенго Сакагути
Нориюки Сато
Хироеки Сахара
Тацуя Фудзита
Original Assignee
Тойо Суйсан Кайся, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тойо Суйсан Кайся, Лтд. filed Critical Тойо Суйсан Кайся, Лтд.
Publication of EA200100967A1 publication Critical patent/EA200100967A1/ru
Publication of EA003098B1 publication Critical patent/EA003098B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

Описывается иммунодепрессивное средство, содержащее в качестве активного ингредиента, по меньшей мере, одно соединение, выбранное из группы, состоящей из соединений, представленных формулойв которой Rи Rпредставляют независимо ацильный остаток высшей жирной кислоты, и их фармацевтически приемлемых солей.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200100967A 1999-03-11 2000-03-02 Новое иммунодепрессивное средство EA003098B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6520899 1999-03-11
JP17688199 1999-06-23
PCT/JP2000/001231 WO2000053190A1 (fr) 1999-03-11 2000-03-02 Nouveaux immunodepresseurs

Publications (2)

Publication Number Publication Date
EA200100967A1 true EA200100967A1 (ru) 2002-02-28
EA003098B1 EA003098B1 (ru) 2002-12-26

Family

ID=26406336

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100967A EA003098B1 (ru) 1999-03-11 2000-03-02 Новое иммунодепрессивное средство

Country Status (14)

Country Link
EP (1) EP1172108B1 (ru)
JP (1) JP3771446B2 (ru)
KR (1) KR100473935B1 (ru)
CN (1) CN1155391C (ru)
AT (1) ATE285240T1 (ru)
AU (1) AU765950B2 (ru)
CA (1) CA2364446C (ru)
DE (1) DE60016908T2 (ru)
DK (1) DK1172108T3 (ru)
EA (1) EA003098B1 (ru)
ES (1) ES2234568T3 (ru)
NO (1) NO329003B1 (ru)
PT (1) PT1172108E (ru)
WO (1) WO2000053190A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003094B1 (ru) 1999-02-26 2002-12-26 Тойо Суйсан Кайся, Лтд. Лекарственное средство, содержащее производное сульфопиранозилацилглицерина
EP1164140B1 (en) 1999-02-26 2003-07-09 Toyo Suisan Kaisha, Ltd. Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs
AU764057B2 (en) 1999-02-26 2003-08-07 Toyo Suisan Kaisha, Ltd. Novel sulforhamnosylacylglycerol derivatives and use thereof as medicaments
WO2003006028A1 (fr) 2001-07-09 2003-01-23 Toyo Suisan Kaisha, Ltd. Nouveaux immunosuppresseurs
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
EP2130834A4 (en) * 2007-07-20 2012-09-05 Toyo Suisan Kaisha NEW SULFONATED SUGAR DERIVATIVE AND ITS USE FOR A MEDICINAL AGENT

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2872694B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 血管内血液凝固症候群の治療剤
JP2872695B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 腎炎の治療剤
JPH07242691A (ja) * 1994-01-17 1995-09-19 Sankyo Co Ltd １位にカルボキシメチレン基を有する４−ホスホノグルコサミン類
JP4454051B2 (ja) * 1997-01-24 2010-04-21 東洋水産株式会社 新規な糖脂質、その製造方法及びその用途
FR2774094B1 (fr) * 1998-01-26 2001-04-13 Ifremer Procede de purification de sulfoquinovosyldiacylglycerol par chromatographie de partage centrifuge

Also Published As

Publication number Publication date
JP3771446B2 (ja) 2006-04-26
DE60016908D1 (de) 2005-01-27
NO20014382L (no) 2001-11-09
EP1172108B1 (en) 2004-12-22
KR20020005613A (ko) 2002-01-17
CN1343121A (zh) 2002-04-03
ES2234568T3 (es) 2005-07-01
AU765950B2 (en) 2003-10-02
EP1172108A4 (en) 2003-10-15
DK1172108T3 (da) 2005-02-07
DE60016908T2 (de) 2005-12-08
CA2364446A1 (en) 2000-09-14
NO329003B1 (no) 2010-07-19
AU2825500A (en) 2000-09-28
KR100473935B1 (ko) 2005-03-08
EA003098B1 (ru) 2002-12-26
PT1172108E (pt) 2005-02-28
EP1172108A1 (en) 2002-01-16
NO20014382D0 (no) 2001-09-10
ATE285240T1 (de) 2005-01-15
CN1155391C (zh) 2004-06-30
CA2364446C (en) 2007-09-25
WO2000053190A1 (fr) 2000-09-14

Similar Documents

Publication Publication Date Title
NO950297L (no) Prolinamidderivater
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
DZ863A1 (fr) Dérivés de benzoxazol et benzothiazolamine.
DE69215965D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DE60032470D1 (de) Heilmittel die sulfopyranosylacylglycerolderivate enthalten
EA200100967A1 (ru) Новое иммунодепрессивное средство
EP1008345A4 (en) ANTI-ALLERGIC AGENTS
BRPI0511824A (pt) radiossensibilizador
CA2452530A1 (en) Novel immunosuppressive agent
ATE197953T1 (de) Pyrrolo(4,3,2-de)chinolin-derivat
DK0421668T3 (da) 1,4-dihydro-4-oxo-3-quinolinderivater som selektivt toksiske, antibakterielle midler til pattedyr
RU94019328A (ru) α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU